AI assistant
Moderna, Inc. — Director's Dealing 2026
Mar 3, 2026
30610_dirs_2026-03-03_e71edc3f-e291-4ca5-8cdf-9351c3458cf1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2026-02-27
Reporting Person: Mock James M (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-27 | Common Stock | M | 329 | — | Acquired | 45553 | Direct |
| 2026-02-27 | Common Stock | F | 160 | $51.71 | Disposed | 45393 | Direct |
| 2026-02-27 | Common Stock | M | 774 | — | Acquired | 46167 | Direct |
| 2026-02-27 | Common Stock | F | 375 | $51.71 | Disposed | 45792 | Direct |
| 2026-02-27 | Common Stock | M | 9901 | — | Acquired | 55693 | Direct |
| 2026-02-27 | Common Stock | F | 4788 | $51.71 | Disposed | 50905 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | Restricted Stock Units | $ | M | 329 | Disposed | Common Stock (329) | Direct | |
| 2026-02-27 | Restricted Stock Units | $ | M | 774 | Disposed | Common Stock (774) | Direct | |
| 2026-02-27 | Restricted Stock Units | $ | M | 9901 | Disposed | Common Stock (9901) | Direct | |
| 2026-03-01 | Stock Option (Right to Buy) | $53.57 | A | 37639 | Acquired | 2036-03-01 | Common Stock (37639) | Direct |
| 2026-03-01 | Restricted Stock Units | $ | A | 49569 | Acquired | Common Stock (49569) | Direct |
Footnotes
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F5: 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F6: 25% of this option will vest and become exercisable on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F7: 25% of the shares subject to this restricted stock unit award will vest on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.